U.S. House Misses Critical Opportunity to Boost Cancer Research and Prevention Funding; Future Progress in Jeopardy
Today, the U.S. House passed The Full-Year Continuing Appropriations and Extensions Act, 2025. It contains no increases for federal cancer research or prevention funding and significant cuts to Congressionally Directed Medical Research Programs (CDMRP), in which cancer is the largest recipient of funds.